Introduction to 2022 Health Trends

Insights for Industry Change Agents

After a year of absolute uncertainty, micro-predictions and near constant recalculations, the picture of our world and what’s next in it is becoming clearer.

If there’s one through line in this year’s report, it’s this: we are an industry working toward?sustainable acceleration in the product management lifecycle. The disruption of the pandemic fueled fast-moving innovation, including untold experience cycles that showed leaders what was possible in a crisis.?

So, what worked and what didn’t? What’s repeatable and important in the now normal?

There are several key themes leading us to what’s next and they start in a critically important place: new models across the spectrum from clinical development to commercialization and everything in between. Biopharmaceutical organizations around the world are validating provisional insights hard-earned in times of rapid change to identify exactly how to best achieve efficiency and effectiveness going forward.

In 2022, clinical development will be focused on Appropriate Acceleration, using innovative study design to optimize speed and improve the likelihood of completing successful, valuable research. Delivering that innovative study design will increasingly rely on real-world data engines, the purposeful use of decentralized patient experiences and dynamic contracting with partners and suppliers.

Commercialization will come full-circle, hinging on an optimization loop that brings together a highly effective field force and highly efficient digital engagement. It includes entrepreneurial field leadership; a digital dimension built on precision, prediction, reach and frequency; and a hard look at how ‘post-pilot deceleration’ – a situation where, say, an entrepreneurial marketing team with a great idea gets too far out ahead of their colleagues – could limit the scale of impact and change.

Underlying both is nothing short of patient-powered design as biopharmaceutical becomes increasingly customer focused, bringing forward patient voices around the world to understand their experiences in care, help co-create new solutions together, and pressure test protocols and pilots before they’re launched.

These new models are standing up in a climate that is incredibly challenged. Our key stakeholders – healthcare professionals (HCPs) – are dealing with high levels of burn out, patient overload and stressed resources. Our own industry is pressured by difficulties in finding and retaining key talent, side by side with renewed dynamism in the market.

There are certainly incredible bright spots as we enter the new year. The push to improve diversity, equity and inclusion – long overdue and still incomplete – Is ascending across our clinical and commercial organizations, actively changing how we engage communities in clinical research, improve access to new therapies and build our own organizations and teams. We’re celebrating a surge in positive reputation, although recent slippage in the polls signals that industry reputation can’t rest on that laurel. And we’re scaling personal, tailored ways to connect with stakeholders – all while uncovering new approaches to supporting healthcare professionals and improving the opportunities available to our teams.

In total, we’re following 10 important new trends in three focus areas for the year ahead:

Focus On: Value Creation

Trend 1:?????????Appropriate Acceleration in Clinical Development

Trend 2:?????????Human + Digital Optimization in the Field

Trend 3:?????????Patient-Powered Design

Focus On: Human Centricity

Trend 4: ????????The Changing Customer Interface

Trend 5:?????????Engaging the Burnt-Out Healthcare Professional

Trend 6: ????????High Expectations For/From High Talent

Focus On: Industry Change

Trend 8:?????????Urgency for Representation

Trend 9:?????????Rx Rep(utation)

Trend 10:???????A New Era of Market Dynamism?

In 2022, we are a new industry. One with evolved commitments, new models, entirely changed stakeholders. How do we do it effectively and efficiently together? Visit trends.health to access more perspectives highlighting key dynamics from 2022 Health Trends.

?

About

Syneos Health??(Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company is purpose-built to accelerate customer performance to address modern market realities. Learn more about how Syneos Health is?shortening the distance from lab to life? by visiting?syneoshealth.com.

?

?